Research
The National Institute of Allergy and Infectious Diseases (NIAID) released its strategy for accelerating research into the diagnosis, prevention, and treatment of COVID-19 this week, establishing four key priorities.
These priorities include improving key knowledge of both COVID-19 and the... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) has struck a partnership with Cytovale to develop a rapid diagnostic system for sepsis as part of the COVID-19 pandemic response.
Cytovale’s rapid diagnostic system analyzes the biomechanical properties of immune cells, which... Read More »
From flooding to wildfires to the novel coronavirus, health emergencies have dominated and redefined public life in the last year. Experts say that keeping Americans safe from these disasters requires a well-funded public health system focused on three key areas: prevention, preparedness, and... Read More »
New York State and Bloomberg Philanthropies are working together on a contact tracing initiative to control the infection rate of COVID-19.
Bloomberg Philanthropies, founded by Mike Bloomberg, has committed $10.5 million, along with organizational support and technical assistance, to build out... Read More »
In a new report titled Developing a National Strategy for Serology in the United States, the Johns Hopkins Center for Health Security argued for the creation of a national antibody testing strategy in the United States to counteract the spread of COVID-19.
One of the major problems for the U.S.... Read More »
Despite high scores on the Global Health Security (GHS) index, the United States has fundamentally weak health security, the Nuclear Threat Initiative (NTI) warns, and its struggle with COVID-19 has emphasized its inadequate ability to deal with a pandemic.
COVID-19 has spawned more than... Read More »
Though 72 potential vaccines and treatments for COVID-19 are currently under development, the U.S. Food and Drug Administration (FDA) and its federal health partners note that urgency for additional products remains, and to jumpstart possibilities, they have launched a new Coronavirus Treatment... Read More »
Pharmaceutical firm Roche said it has developed and would soon launch its test detecting antibodies in people exposed to the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) that causes COVID-19.
The Elecsys Anti-SARS-CoV-2 serology test can support priority screening of high-risk... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) and Tangen Biosciences, Inc. are teaming up to develop a rapid diagnostic test for SARS-CoV-2, capable of producing results within an hour.
The test will be paired with the Tangen GeneSpark, a molecular diagnostic system, and... Read More »
Novartis is proceeding with a Phase III clinical trial to evaluate the use of hydroxychloroquine for the treatment of patients with COVID-19 disease.
The company got the go-ahead from the US Food and Drug Administration (FDA). The trial will involve approximately 440 patients and be conducted at... Read More »
Animal testing of the Gilead Sciences Inc.-created antiviral Remdesivir showed promise against rhesus macaques infected with SARS-CoV-2, the virus responsible for COVID-19, National Institutes of Health (NIH) scientists said.
This study was led by the NIH’s National Institute of Allergy and... Read More »
A universal Ebola vaccine may fight all four virus species that infect humans, according to preclinical tests of a new treatment at the Cincinnati Children’s Hospital Medical Center.
Data published in the Journal of Virology shows the virus could work as a stand-alone protection, but may also... Read More »
In a teleconference between experts from the Immunization Action Coalition, FasterCures and the U.S. Food and Drug Administration (FDA) on Friday, one thing was made abundantly clear: the world needs the best possible vaccines to combat COVID-19 as quickly as possible.
In the opinion of Dr.... Read More »
The Biomedical Advanced Research Development Authority (BARDA) is working with Hememics Biotechnologies to develop a rapid antigen and antibody test to identify the COVID-19 coronavirus in 60 seconds.
The test will be designed to detect the SARS-CoV-2 antigen, which causes COVID-19, from nasal... Read More »
The U.S. Food and Drug Administration (FDA) announced that a recent collaboration including U.S. Cotton, UnitedHealth Group, Quantigen, and the Gates Foundation has resulted in further COVID-19 testing option expansion.
Officials said the determination that spun synthetic swabs, with a design... Read More »
Sen. Ron Johnson (R-WI) has forwarded correspondence to President Donald Trump, encouraging efforts to provide COVID-19 patients the right to try hydroxychloroquine (HCQ) in the course of their diagnosis.
Johnson is seeking to have the president issue a directive to remove the Food and Drug... Read More »
Moderna is working toward U.S. Food and Drug Administration (FDA) licensure on an mRNA vaccine for SARS-CoV-2 -- the virus that causes COVID-19 -- with a $483 million award from the Biomedical Advanced Research and Development Authority (BARDA).
“Vaccines are a critical tool for saving lives... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) is partnering with the American Red Cross (ARC) to recruit blood donors who have recovered from COVID-19.
BARDA and the ARC are working with the U.S. Food and Drug Administration (FDA) to collect convalescent plasma for use as a... Read More »
National Institutes of Health (NIH) scientists maintain N95 respirators can maintain functional integrity for up to three uses when decontaminated effectively.
The findings stem from a study conducted in a controlled laboratory setting. The results are not yet peer-reviewed but are being shared... Read More »
Harried by an ongoing shortage of personal protective equipment for some of the emergency responders who need it most amid the COVID-19 pandemic -- firefighters and EMS workers -- the International Association of Fire Chiefs (IAFC) is pitching a survey they hope to present directly to President... Read More »
Efforts begun on a SARS-CoV-2 vaccine in February are moving closer to fruition for the Biomedical Advanced Research and Development Authority (BARDA) and Sanofi Pasteur, with the announcement of pending non-clinical studies and a Phase 1 clinical trial.
These trials will determine the initial... Read More »
Researchers and engineers from the University of Illinois at Urbana-Champaign and Carle Health launched an effort to produce face shields for health professionals responding to the COVID-19 pandemic.
It stems from a personal protective equipment (PPE) design initiative led by The Grainger... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) is working with Vela Diagnostics USA to develop a rapid diagnostic test for the COVID-19 pandemic.
The rapid diagnostic test would be for use on two instrument platforms, which is needed to test as many people as possible and... Read More »
The push for convalescent plasma and hyperimmune globulin immunotherapies to use against COVID-19 continues at the federal level, with the U.S. Department of Health and Human Services (HHS) touting collaboration with non-governmental entities to see it done.
These immunotherapies could... Read More »
University of Maryland School of Medicine (UMSOM) officials said a new $2.5 million State of Maryland funding allotment would aid in initiating a broader COVID-19 testing initiative expanding testing capability.
"The state is in dire need of increased coronavirus testing, and the School of... Read More »
Rutgers University gained emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) this week for a new test utilizing saliva to detect SARS-CoV-2, the virus that causes COVID-19.
The test comes from Rutgers’ RUCDR Infinite Biologics, the world's largest... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) will pump approximately $180,000 into a new partnership with DiaSorin, Inc. to create a clinical lab test capable of identifying people infected with and recovered from the SARS-CoV-2 virus.
SARS-CoV-2 is the virus that causes... Read More »
The United Nations Foundation is awarding $10 million to CEPI, the Coalition for Epidemic Preparedness, to develop a COVID-19 vaccine.
This award is through the UN Foundation’s COVID-19 Solidarity Response Fund for the World Health Organization (WHO). The fund was set up to raise funds for... Read More »
One of the major problems facing governments and healthcare professionals alike in dealing with the COVID-19 pandemic has been the undetected, asymptomatic cases throughout the world, but the National Institutes of Health (NIH) now aims to track the previously unnoticed.
A study to be conducted... Read More »
The malaria and arthritis drug much-touted by President Donald Trump, hydroxychloroquine, is getting its chance under the microscope now, with the beginning of a clinical trial by the National Institutes of Health to determine its potential as a COVID-19 therapy.
Testers hope the drug could have... Read More »
Every day during the COVID-19 pandemic seems to bring word of a new potential vaccine, treatment or diagnostic being considered or pursued, but the vaccine R&D team at the Coalition for Epidemic Preparedness Innovations (CEPI) has made them easier to track.
In a new analysis published in Nature... Read More »
University of Pittsburgh School of Medicine researchers maintain when tested in mice a potential vaccine against SARS-CoV-2, the new coronavirus causing the COVID-19 pandemic, produces antibodies for potential neutralization.
The study findings detailed via eBioMedicine, which is published by... Read More »
The Department of Homeland Security’s (DHS) Science and Technology Directorate (S&T) is seeking participants for its third 2020 GPS Testing for Critical Infrastructure (GET-CI) event later this year.
“Accurate and precise position, navigation and timing (PNT) information is vital to the... Read More »
Actemra, a drug more commonly used to treat moderate to severe rheumatoid arthritis, will undergo a Phase 3 clinical trial for its potential to help patients suffering from COVID-19, under an expanded partnership between Roche’s Genentech and the Biomedical Advanced Research and Development... Read More »
Global healthcare company Grifols is collaborating with the Biomedical Advanced Research and Development Authority (BARDA) and the United States Department of Defense (DoD) to collect plasma and create a COVID-19 treatment based on it.
The effort is based on previous government calls for... Read More »
